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In this study we describe novel polyionic dendrimer – PEG hydrogels for drug delivery. 
Hydrogels have a crosslinked insoluble network of polymer chains, which have found 
many applications including drug delivery and tissue regeneration. Dendrimers provide 
an ideal platform for drug delivery as they possess a well-defined highly branched 
nanoscale architecture with many reactive surface groups. Their highly clustered 
surface groups allow for targeted drug delivery and high drug payload to enhance 
therapeutic effectiveness. This study presented a new type of polyionic hydrogels based 
on dendrimers with potential applications in drug delivery and tissue engineering. 
 Polyethylene glycol (PEG) with various chain lengths [1500, 6000 , 12000 Da] was first 
conjugated to the Starburst™ G3.0 PAMAM dendrimer to form stealth dendrimers 
through one ending site of PEG using p-nitro phenyl chloroformate and Triethylamine. 
The free hydroxyl group of PEG was further converted to an acrylate group using 
acrolyl chloride and Triethylamine. The conjugation was characterized with 1H-NMR. 
The Ninhydrin assay was used to estimate the loading degree of PEG on the dendrimer 
surface. The molecular weight and loading degree of PEG was varied. Hydrogel 
formation was realized by subjecting dendrimer-PEG acrylate to UV exposure for a 
brief period of time at the presence of Eosin Y, Triethanolamine [TEOA] and 1 vinyl 2 
Pyrrolidinone [NVP] photo initiator system. Viscosity increase was observed after 
hydrogel formation. PEGylated G3.0 PAMAM dendrimer served as cross-linking agent 
to form hydrogels because of its multiple functionalities. PEGylated half generation 
dendrimer G3.5 was subjected to hydrogel formation and its swelling behavior was 
studied.  Better hydrogel formation was observed with increased PEG arm length. The 
surface charges conferred by terminal groups on the dendrimer surface made the 
hydrogel polyionic with controllable charge density. This new type of hydrogel has 
many favorable biological properties such as non toxicity and non immunogenecity and 
multifunctional ties for a variety of in vivo applications. Current studies have 
demonstrated feasibility of chemistry and hydrogel formation. The swelling studies 
demonstrated pH sensitive behavior. Degradation of hydrogel was observed, for low 
PEGylated dendrimer degradation also demonstrated pH sensitivity. Controlled drug 
delivery and release were also investigated. Hydrophobic drug Cyclosprine A was used, 
 we envision that hydrophobic dendrimer core will used for drug encapsulation and 
delivery, and later release in controlled fashion. The polymer and hydrogels were 
evaluated for in vitro cytotoxicity and cell internalization. 
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CHAPTER 1 Introduction 
 
Diseases have been overpowering mankind for a long time. Researchers have 
been actively working to develop therapeutic molecules for disease treatment. With new 
therapeutic agents being developed a major question rises about the effective delivery of 
these molecules to the target site with minimal side effects. Efforts are being made to 
develop hydrogels for drug delivery. In general, hydrogels have a polymer network, 
which is able to absorb and retain water, encapsulate therapeutic molecules and later 
allow sustained and controlled drug release. Various natural and synthetic materials 
have been used to form hydrogels. Hydrogels can be classified into ionic, non ionic, and 
neutral hydrogels. Ionic hydrogels have the ability to respond to the change of pH, 
hence termed as pH sensitive hydrogel. Ionic hydrogels have two main structure 
features: a penetrable network and a number of fixed charges. The penetrable network 
allows the exchange of solute and water. Fixed charges are responsible for the 
regulation of the electrochemical balance between the hydrogel and the surrounding 
medium. The swelling of ionic hydrogels is governed by pH 1. For instance, a hydrogel 
network containing acidic groups swells at high pHs but shrinks at low pHs 2. Therefore 
ionic hydrogels have been used for delivery of various therapeutics and controlled drug 
release based on pH adjustment 3, 4.  
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The objective of this study was to develop a novel polyionic hydrogel based on 
polyamidoamine (PAMAM) dendrimers. PAMAM dendrimers have demonstrated great 
promise for a variety of biomedical applications because of their many attractive 
features including well-defined nanoscale chemical structure, globular shape, low 
polydispersity (close to 1.0), biocompatibility, and a number of reactive surface groups 
5. Dendrimer has a highly branched nanoscale structure, which falls into the range of the 
sizes of biological components within the body. PAMAM dendrimers possess a number 
of charged surface groups (i.e., amine or carboxylate), which can confer pH sensitivity 
and can be used for forming ionic hydrogel with proper modification such as 
crosslinking. In addition, the core of dendrimer is capable of encapsulating hydrophobic 
compounds. Compared with linear polymers, their many accessible reactive end groups 
at the surface are more suitable to deliver agents of interest and achieve a high payload 
within a compact scaffold 6, 7. Developing a dendrimer-base polyionic hydrogel network 
will integrate the structural advantages of both dendrimer and hydrogel. In this study 
PEG was used as a spacer to link individual dendrimer molecules. Covalent attachment 
of PEG to the dendrimer was on the basis of its many useful properties such as 
biocompatibility, stealth properties, prevention of protein absorption, etc. The project 
aims to: 1) explore optimal hydrogel formation conditions; 2) determine the effect of 
polymer structure on gel formation; and 3) evaluate its pH sensitivity, degradation and 
cytotoxicity as well as drug release. 
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CHAPTER 2 Background 
 
 Polymeric drug delivery systems have been extensively studied in order to solve 
the potential problems associated with drugs or bioactive molecules including toxicity, 
site dependence, low effectiveness, poor solubility, short half life, rapid degeneration 
and rapid clearance form the body, etc 8. Polymeric drug delivery systems can help: 
1. Reduce toxic effects on the healthy tissue and reach sites that are conventionally 
inaccessible due to the presence of various barriers 9 by targeted drug delivery; 
2. Increase the half-life of drugs, preventing their rapid degradation, and reduce the 
rate of elimination, thus maintaining drug concentration within a therapeutically 
effective window; 
3. Reduce the amount of drug required to achieve therapeutic efficacy; 
4. Cut down the number of repeated invasive dosage required for certain 
conditions and thus helps to improve patient’s compliance and offers better 
living. 
Considering various properties such as flexibility, structure, biocompatibility, and 
hydrophilicity, three dimensional matrices, hydrogels, are being extensively used as 
drug delivery carriers 10. 
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2.1 Classification of hydrogels 
 
Hydrogels can be classified based on different criteria. 
Table 1. Classification of hydrogels10 
Classification Types 
Source Natural  
Synthetic 
Component Homopolymer (one type of hydrophilic polymer) 
Copolymer (two types of plolymers, at least one 
hydrophilic 
Multipolymer  (more than three types of polymers) 
Interpenetrating polymer network 
Electric or Ionic charge Neutral hydrogels 
Anionic hydrogels 
Cationic hydrogels 
Ampholytic hydrogel 
Structure Physical structure 
Amorphous hydrogels (chains randomly    arranged) 
Semicrystalline hydrogels (dense regions of ordered 
macromolecules, i.e. crystallites)10 
Hydrogen-bonded hydrogels 
Crosslinked 
Covalent bond 
Intermolecular force 
Functions Biodegradable 
Stimuli responsive 11 
pH, light, temperature, etc
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Table 2. Commonly used natural and synthetic polymers for hydrogel preparation 10 
Type Example
Natural Chitosin 
Alginate 
Fibrin 
Gelatin 
Collagen 
Dextran 
Hyaluronic acid Acrylic acid (AA) 
 Synthetic Hydroxyethyl methacrylate (HEMA) 
N-(2-hydroxypropyl) methacrylate (HPMA) 
N-vinyl-2-pyrrolidone (NVP) 
N-isopropyl acrylamide (NIPAAm) 
Vinyl acetate (VAc) 
Methacrylic acid (MAA) 
Polyethylene glycol acrylate/methacrylate 
(PEGA/PEGMA) 
 
 
2.1.1 Homopolymeric and copolymeric hydrogels  
 
Homopolymer is composed of a number of identical monomer units. Homopolymeric 
hydrogels may have a crosslinked or uncrosslinked network. Crosslinked 
homopolymeric hydrogels can be used to develop sustained and controlled drug 
delivery devices, contact lenses, etc. Some of the crosslinked homopolymers that have 
been used are poly (hydroxyalkyl methacrylate) derivatives include poly (3- 
hydroxypropyl methacrylate (PHPMA), poly (glyceryl methacrylate) (PGMA) and poly 
(2-hydroxyethyl methacrylate) (PHEMA) 12. Uncrosslinked homopolymers have also 
been used for forming hydrogels, such as poly (N-vinyl-2-pyrrolidinone) (PNVP) 13, 
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poly(acrylamide) (PAM), poly(ethylene glycol) (PEG) and poly(vinyl alcohol) (PVA). 
However, uncrosslinked hydrogels have poor network stability. Copolymeric hydrogel 
networks are comprised of two or more different monomers, which are arranged in 
block or alternating configuration along the chain of the polymer. One of copolymeric 
hydrogel examples is based on N-vinyl-2-pyrrolidone (NVP) and polyethylene glycol 
diacrylate (PAC) 14.  
 
 
2.1.2  Interpenetrating polymer networks 
 
Typically interpenetrating polymer networks (IPNs) combine two polymers in a single 
hydrogel network. To be considered as IPN, three conditions should be satisfied: (1) the 
two polymers are synthesized and/ or crosslinked in the presence of the other, (2) the 
two polymers have similar kinetics, and (3) the two polymers are not dramatically phase 
separated 15. As the two polymer components incorporated in IPN are not covalently 
bound but at the same time inseparable form the network, IPN can retain characteristics 
of both polymers 2. One or both macromolecules of the IPN could be biodegradable 16. 
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2.1.3 Ionic or nonionic hydrogels 
 
Ionic hydrogels, also known as polyelectrolytes, can be prepared from monomer 
possessing ionic charges. The charges can either be positive or negative; therefore, the 
hydrogels can either be cationic or anionic, respectively. These hydrogels can respond 
to pH change and hence are also termed as pH sensitive hydrogels. Hydrogels can even 
possess both negative and positive charges which are known as polyampholytic 
hydrogels17. The swelling of ionic hydrogels is affected by the ionic interactions 
between the charged polymer chain and free ions in the medium 18. For example, ionic 
hydrogels containing carboxylate groups can absorb a larger amount of water at a pH 
higher than its pKa because of increased hydrophilicity. 
Neutral hydrogels, as the name suggests, do not possess any charged groups. These 
hydrogels swell to equilibrium when the osmotic pressure of the solvent is balanced 
with the sub-chain stretching energy. The driving force for swelling is the water-
polymer thermodynamic mixing contribution to the overall free energy, and elastic 
polymer contribution 10. Ionic hydrogels can help to achieve controlled drug release and 
may increase the residence time of the hydrogel at the target site. Poly(methacrylic acid-
co-methacryloxyethyl glucoside) and poly(methacrylic acid-g-ethylene glycol) 
hydrogels were reported for insulin delivery, where insulin can be slowly released in 
acidic medium while at a faster rate in alkaline medium. Ionic hydrogels are also used 
for self controlled delivery system 19. Polyacrylic acid (PAA) and chitosan (CS) have 
been used to formulate hydrogels for sustained release of amoxicillin in the stomach 20.  
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2.2 Hydrogel preparation  
 
Hydrogel can be prepared by chemically or physically crosslinking polymers. Some 
commonly used methods are listed in Table 3. 
Table 3.  Preparation methods for hydrogels 12 
Chemically Crosslinking Physically crosslinking 
Radical polymerization 
Chemical reaction of complementary 
groups 
Addition reactions 
Condensation reactions 
High energy  radiation 
Enzymes 
Ionic interactions 
Crystallization 
Crystallization in homopolymer systems 
Stereocomplex formation 
Physically crosslinked hydrogels from 
amphiphilic block and graft copolymers 
Crosslinking by hydrogen bonds 
Crosslinking by protein interactions 
Use of genetically engineered proteins 
Crosslinking by antigen–antibody 
interactions 
 
 
2.2.1 Chemically crosslinked hydrogels 
 
Chemically crosslinked hydrogels are prepared in the presence of chemical crosslinking 
agent 12. Chemically crosslinking imparts structural stability to the network. However, 
crosslinkers should be non-toxic in order to retain the biocompatibility properties of the 
gel. There are many methods to realize crosslinking chemically. Crosslinking can be 
initiated by radical polymerization. The process involved is radical polymerization of 
low molecular weight monomers in the presence of crosslinking agents, for example 
hydrogel formation via the polymerization of HEMA in the presence of a suitable 
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crosslinking agent (e.g. ethylene glycol dimethacrylate). Polymer chains can be 
crosslinked to form a network by chemical reaction of complementary groups, through 
which functional groups and complementary reactive groups react to form covalent 
bond, such as amine-carboxylic acid or isocyanate-OH/NH2 reaction, or Schiff base 
formation. Polymers with hydroxyl groups (e.g. poly (vinyl alcohol) (PVA)) can be 
crosslinked by using glutaraldehyde, amine containing polymers can be crosslinked by 
Schiff base 21. 
Hydrogel can also be formed from the water soluble polymers with higher functional 
crosslinking agent using addition reaction. For example polysaccharides can be 
crosslinked with divinylsulfone 22. The properties of the hydrogel network can be 
controlled by varying the concentration of the dissolved polymer and the amount of 
crosslinking agent. In the method of crosslinking by condensation reaction, the 
commonly used crosslinking agent to crosslink water soluble polymers with amide 
bonds is N, N-(3-dimethylaminopropyl)-N-ethyl carbodiimide (EDC) 23.  
Alternatively gamma radiation and electron beam methods are used to form hydrogels. 
For example, hydrogel can be formed by subjecting water soluble polymers derivatized 
with vinyl groups to high energy radiation 24. Hydrogels are also formed from polymers 
having acrylate end groups by using a suitable photoinitiator 25. Polyvinyl alcohol and 
PEG can be modified to have acrylate groups for hydrogel formation based on this 
method 26. In addition the use of enzymes as crosslinking agents has been explored. For 
example, transglutaminase was applied to crosslink functionalized PEG and a lysine-
containing polypeptide 27. 
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2.2.2 Physically crosslinked hydrogels 
 
A major drawback of chemically crosslinked hydrogels is that the presence of 
crosslinking agents may cause toxic effects and raise hindrance for loading of 
therapeutic agents within the matrix 12. Physically crosslinking utilizes noncovalent 
interactions between polymer chains to form hydrogels. This helps to eliminate the 
toxic effects imparted by chemical crosslinking agents. Ionic interactions can cause 
hydrogel formation, such as alginate 28. Chitosan-based hydrogels have been formed 
with glycerol-phosphate disodium salt 29. The crystallization method including alternate 
freezing and thawing is also one of the ways of forming hydrogels. One example is 
water soluble poly(vinyl alcohol) PVA. It can form a highly elastic hydrogel 30. 
Stereocomplex formation between enantiomeric oligomeric lactic acid chains can form 
hydrogel. Polylactic acid (PLA) is one such polymer which can form stereocomplex, 
first reported by Ikada et al 31. Examples include PLLA–PEG–PLLA and PDLA–PEG–
PDLA stereocomplex 32, pHEMA (poly(HEMA-g-oligolactate)s) etc. Hydrogel can also 
be formed after mixing aqueous solutions of dex-(l)-lactate (l-lactic acid oligomer 
grafted to dextran) and dex-(d)-lactate 33. Some types of polymers such as amphiphilic 
diblock copolymers, multiblock copolymers or graft copolymers can self assemble into 
an organized structure to form hydrogels 12, 34. Hydrogels can also be formed via 
hydrogen bonding 35, 37. Crosslinking by protein interactions is another way to prepare 
physically crosslinked hydrogels. In particular genetic engineering has been applied for 
preparation of hydrogels based on protein interactions. DNA determines protein 
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synthesis. Therefore its physical and chemical properties can be precisely controlled by 
changing synthetic DNA sequences with genetic engineering tools 12, 38. Proteins exhibit 
coiled structures formed from helices. Conjugation of proteins to synthetic polymers has 
been used to take advantage of the properties of both proteins and synthetic polymers. 
Hybrid hydrogels can be formed on the basis of polymer poly (N-(2-
hydroxypropyl)methacrylamide) (PHPMA) and two types of coiled proteins: natural 
(motor protein kinesin) and synthetic (HHHHHH-(randomly structured tail)-
(VSSLESK)6) 39. Antigen-antibody reaction has also been used to form interpenetrating 
polymer network by immobilizing both antigen and antibody to polymer chain. For 
example, rabbit immunoglobulin G (rabbit IgG) and goat anti-rabbit IgG (GAR IgG) as 
the antigen and antibody for hydrogel formation have been explored 40. 
 
2.3 Properties of hydrogels 
 
Synthetic hydrogels are crosslinked insoluble polymer networks that swell in aqueous 
solutions and have been widely used because of their biologically favorable properties 
such as biocompatibility, high capacity for water absorption similar to hydrodynamic 
properties of hydrogels formed from natural material and to that of biological tissues 18, 
as well as their minimal mechanical irritation due to their soft and rubbery state 41. 
Hydrogels have found applications in controlled drug delivery and release, gene 
delivery, wound healing and tissue scaffolding 42, 43. The properties of hydrogels can be 
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modulated through appropriate engineering of polymer structures that form the network 
of the hydrogel.  
In particular, hydrogel based drug delivery systems should meet the requirements of 
certain pharmacological parameters including bioavailability, biodistribution and 
pharmacokinetics. Bioavailability is defined as the measure of therapeutically active 
drug that reaches the systemic circulation and is available at the site of action. These 
systems thus help to increase the half life of the administered drugs and improve their 
bioavailability.  The way, in which the targeted biomolecule’s path of travel within the 
experimental subject is tracked, is termed as biodistribution. The deposition of the drug 
in various tissues can be modified by targeting a specific tissue or cell type of interest 
based on hydrogel drug delivery systems. Nowadays challenges exist in developing 
drug delivery systems for avoidance of toxicity, controlled biodegradation and 
subsequent elimination from the body, and cost reduction for manufacturing. Hydrogels 
should be nontoxic and preferably biodegradable. The toxicity of hydrogels can arise 
due to un-reacted monomers, oligomers or photo-initiators. In order to create 
biocompatible hydrogels, repeated washing is necessary to eliminate contaminants from 
hydrogels. Also, kinetics of polymerization should be thoroughly studied so as to 
achieve enhanced conversion rates, hence minimizing un-reacted monomers and side 
product. 
In most cases the mechanical strength of hydrogels is not of major importance, as for 
drug delivery the network eventually breaks down. But for applications in which the gel 
matrix needs to maintain the mechanical integrity such as adhesive sealants for wound 
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closure, hydrogel should possess a certain degree of mechanical stability. Mechanical 
stability of the hydrogel is also needed when the hydrogel is required to withstand 
environmental conditions within the body such as extreme pH, before it reaches the 
target site. Meanwhile, it should be mechanically flexible enough to facilitate release of 
incorporated therapeutic agents. Thus a balance between mechanical strength and 
flexibility is essential. For instance, tissue adhesive hydrogels should be mechanically 
stable to resist forces within the body such as intraocular pressure when the gels are 
used to seal the ocular wounds, or external forces such as pressure and shear force for 
wound healing applications. 
 
 
2.4 Hydrogels for drug delivery 
 
Hydrogels now play an important role in drug delivery. Hydrogels as cell adhesion 
resistant surface have been used to prevent thrombosis after surgery. Hydrogels have 
compatibility with blood and other body fluids, thus their application can be extended 
for forming contact lenses, wound dressings, membranes, and as coating applied to 
living tissue surfaces. Hydrogel can encapsulate cells and allow them to proliferate, 
differentiate, and organize, indicating their potential in tissue engineering scaffolding. 
Drug delivery has been a major application for hydrogels. Hydrogels of various 
functionalities can be developed to meet different biomedical requirements. Stimuli-
sensitive hydrogels can respond to changes in various parameters such as pH and 
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temperature to achieve controlled drug release. For instance the digestive tract has a pH 
range from 4-8. Controlled drug release can be realized in the digestive tract by 
designing a pH sensitive hydrogel. Hydrogel based delivery can be used for epidermal 
and subcutaneous application. If hydrogels exhibit tissue adhesiveness they can be used 
towards applications such as closure wound healing for various tissues or organs. In 
addition this adhesive property can be used for drug delivery through mucus membranes 
to achieve non-invasive drug administration. Hydrogels having “stealth” properties due 
to presence of PEG have extended in vivo circulation by preventing the activation of the 
host immune response such as, phagocytic activity 44. 
 
 
2.4.1 Oral drug delivery 
 
Oral administration of drug has been practiced for a long time because of the ease of its 
application. Hydrogels have been used for maximizing the absorption of the drug 
administered. pH-Sensitive chitosan– polyvinylpyrrolidone (PVP) based semi-
interpenetrating polymer network have been reported to deliver drugs to treat gastric 
ailments 45. Glucose sensitive hydrogels have been reported for effective delivery of 
glucose. These hydrogels are composed of glucose-containing polymers and PEGylated 
concanavalin A 46. Many mucoadhesive hydrogels have found use for mucosal drug 
delivery as the mucosa has a rich blood supply and is permeable to many drugs. 
Polymers used for hydrogel formation is based on their adhesive properties including 
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synthetic polymers such as monomeric cyanoacrylate , polyacrylic acid , hydroxypropyl 
methylcellulose, and poly methacrylate derivatives as well as naturally occurring 
polymers such as hyaluronic acid  and chitosan. In addition other synthetic polymers 
such as polyurethanes, epoxy resins, polystyrene, and natural-product cement have also 
been extensively investigated for the preparation of mucoadhesive hydrogels. Proteins 
must overcome three natural barriers in the human body: (1) acidic and enzymatic 
degradation in the stomach; (2) enzymatic degradation in small intestine; and (3) poor 
intestinal absorption 47.  These hydrogels undergo enzymatic degradation at the desired 
site.  Delivery of drug like beclomethasone dipropionate for the treatment of irritable 
bowel syndrome has been proposed 48. The colonic region has also been considered as a 
possible absorption site for orally administered proteins and peptides due to its low 
proteolytic activity. 
 
 
2.4.2 Rectal drug delivery 
 
Hemorrhoids are a commonly occurring rectal disease, which requires an effective drug 
adsorption at the site rather than a systemic distribution.  This need can be addressed by 
the use of bioadhesive hydrogels that can release drug to the site in a controlled manner 
and allow for effective removal via biodegradation. Tissue adhesive gels overcome the 
drawback of slippage of the material in situ at the same time non-irritable to the rectal 
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tissue 49. The use of xyloglucan polysaccharide gels for rectal drug delivery has been 
demonstrated 50.  
 
 
2.4.3 Ocular drug delivery 
 
Eye has various defensive barriers to prevent entry of foreign substances, including 
effective tear drainage, blinking, and low permeability of the cornea. The existences of 
these defensive barriers only allow limited drug absorption. Thus repeated doses are 
needed in order to achieve expected treatment efficacy. To reduce repeated dosing and 
increase the half life of drugs 51, various approaches have been used such as suspension 
and ointments, which can be retained in the eye. But their presence causes discomfort to 
patients and sometimes even leads to adverse reactions. Hydrogels seem to be a suitable 
carrier for ocular drug delivery because of their physical properties such as elastic and 
rubbery texture and insolubility in water which resists the ocular drainage system. This 
system can help achieve better retention and absorption of drugs with the utility of 
tissue adhesiveness. Further, hydrogels containing drugs can be formed in situ. In situ 
hydrogel formation caused by temperature and pressure are also under development and 
may lead to new ocular drug delivery systems. Hydrogels based on hydroxyethyl 
methacrylate (HEMA) crosslinked with ethylene glycol dimethacrylate (EGDMA) have 
been developed for ocular drug delivery 52, 53. 
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2.4.4 Vaginal drug delivery 
 
Vagina is one of the important sites for drug delivery. In situ gel forming polymers that 
are temperature sensitive have been reported for prolonged and effective release of 
active drugs such as nonoxynol-9, progestins, estrogens, peptides and proteins49, 54. 
Poloxamers and polycarbophil can also form thermo-sensitive hydrogels for the 
treatment of fungal diseases especially vaginitis 55. 
 
 
2.4.5 Transdermal drug delivery 
 
Insulin delivery has been reported through the transdermal route using poloxamer gel 56, 
which contained a combination of chemical enhancers and iontophoresis to facilitate 
insulin permeation. This method can also be used for delivery of hormones. Local drug 
delivery for wound healing is another example of transdermal drug delivery. Hydrogels 
based on poly(methacrylates) and polyvinylpyrrolidine 57 as well as commercially 
available hydrogel such as Nu-gelTM  have been utilized for transdermal drug delivery. 
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CHAPTER 3 Experimental methods and material 
 
3.1  Materials 
In this research work, chemicals of high purity were utilized as received from the 
suppliers 
Materials Abbreviation 
Polyethylene glycol diol [OH-PEG-OH]  
MW 1500, 6000, 12000 
PEG 
Starburst™ G3.0 PAMAM dendrimer (20 
wt % solution in methanol) 
G3.0 
Starburst™ G3.5 PAMAM dendrimer (20 
wt % solution in methanol) 
G3.5 
Triethylamine TEA 
1-vinyl-2 Pyrrolidinone NVP 
4-nitro phenyl chloroformate 4-NPC 
Ethyl ether(anhydrous)  
N,N-dimethylformamide DMF 
Acrolyl chloride  
Ethanol(denatured)  
Ninhydrin  
Eosin Y  
Triethanolamine TEOA 
Dimethoxyphenyl Acetophone DMPA 
Tetrahydrofloron THF 
Deuterium oxide D 2 O 
Fluorescein 5(6)-isothio-cynate 90% FITC 
Irgacure 2959  
Hydrochloric Acid HCl 
N,N'-Dicyclohexylcarbodiimide DCC 
Ethanol  
4-Dimethylaminopyridine DMPA 
Phosphate buffer solution PBS 
Cell line RAW264 mouse macrophages  
DMEM medium supplemented with 10%  
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fetal calf serum, 100 µ/ml penicillin-
streptomycin 
Trypsin solution  
Trypan blue  
Deionized water DI water
Sodium hydroxide  
 
 
3.2 Equipment 
Table 4.  List of the Equipment used  
Name  Purpose 
Weighing Balance For measuring the required amount of 
materials 
Eppendorf Centrifuge Model: 5415 D For Centrifugation, separation of the 
suspended phase form liquid phase 
Ultra Violet – Visible (UV-Vis) 
Spectrophotometer 
Quantitative analytical tool for ninhydrin 
assay and release experiments. 
UV Radiation source A 90 W high-pressure mercury vapor filled 
lamp, manufactured by Phillips (Holland), 
was used as the ultra violet (UV) light source
Nuclear Magnetic Resonance (NMR) 
Spectrometer 
Proton NMR measurement were carried out 
on 300 MHz NMR spectrometer 
FTS System Freeze dry system to dry the frozen samples 
Rotary Evaporator For evaporating the solvents used in the 
experiment for obtaining the polymer 
Scanning Electron microscope [ ZESIS 
EVO50 SEM] 
To take the SEM pictures for studying the 
internal structure and organization of 
Polymers 
Fluorescent Microscope Cell internalization assay
Hemacytometer For cell counting in cell cytotoxicity assay 
Binocular microscope Cell studies 
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3.3  Synthesis 
 
3.3.1 Conjugation of PEG to full generation PAMAM dendrimer G3.0 
 
As illustrated in Figure 1, one hydroxyl end group of PEG diol (3 different molecular 
weights used 1500, 6000 and 12000 Da) was activated first with 4-NPC and TEA to 
form OH-PEG-NPC conjugates. Briefly 0.4 mmol of PEG was dissolved in 40 ml of 
THF. To this solution 0.45 mmol (80.6mg) of 4-NPC and 0.4 mmol of TEA were added 
dropwise. The mixture was stirred for 24 hrs, and then centrifuged at 10 rpm for 10 
minutes to filter off the salt. The supernatant was precipitated in ethyl ether (40 ml) and 
kept at -40 ºC for further precipitation. After 24 hrs, the precipitate was collected and 
dried using freeze dry system (FTS) to obtain OH-PEG-NPC conjugates. OH-PEG-NPC 
was then reacted with PAMAM dendrimer generation 3.0 (where the molar ratio of 
PEG-NPC/dendrimer was 32:1) in DMF for 72 hours forming PEGylated dendrimer 
conjugate. This solution was precipitated in 50 ml of ethyl ether and kept at -40 ºC for 
further precipitation. The precipitate was collected and freeze dried with FTS 58. 
Dialysis was carried out to remove excess of PEG for further purification of the product. 
The resulting G3.0-PEG-OH was then freeze dried. The degree of PEGylation on the 
dendrimer as well as the molecular weight of G3.0-PEG-OH was characterized with 
ninhydrin assay and 1 H-NMR spectroscopy. 
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Figure 1. Conjugation of PEG to the dendrimer 
 
O
O
Cl
O2N
+
THF
TEA
O
O
O
O
H
O2N
n
m
OH
O H
n
G 3.0
DMFPAMAM dendrimer G3.0
NH
O
O
O
H
n  
 
The feeding molar ratio of OH-PEG-NPC/ dendrimer was reduced to 4:1 to prepare a 
lower degree of PEGylation on the dendrimer surface following the same procedure as 
described above. 
 
 
3.3.2 Conjugation of PEG to half generation PAMAM dendrimer G3.5 
 
Conjugation of PEG to half generation PAMAM G3.5 involved the activation of 
carboxyl (-COOH) groups of the dendrimer using DCC and DMAP. Prior to the 
reaction, 1µmol of PAMAM G3.5 was dried via rotary evaporation. The obtained dry 
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product was then dissolved in 1 ml of DI water. The solution was then acidified with 3 
drops of 1 Normal HCl. The acidified solution was dried again by rotary evaporation 
and then re-dissolved in 2 ml of DMF. To this solution PEG diol was added, followed 
by the addition of DCC and DMAP where the feeding molar ratio of PEG diol: DCC: 
DMAP: G3.5 was 64:64:64:1. The solution was stirred for 24 hrs at 4 ºC. After 24 
hours the solution was added dropwise to cold ether and kept at -40 ºC for 24 hrs. The 
precipitate was obtained by centrifugation. Dialysis was carried out to remove un-
reacted DCC, PEG, and DMAP for further purification of the product. The product thus 
recovered was G3.5-PEG-OH. The degree of PEGylation was then determined by 1 H-
NMR. 
 
 
3.3.3 Conversion of free hydroxyl group of PEG to an acrylate group 
 
As shown in Figure 2, PEG diol was acrylated in order to make photo-initiated 
crosslinking reaction possible. To convert the free hydroxyl group of PEG on the 
dendrimer surface to an acrylate group, the reaction procedure involved the following 
reagents: dendrimer-PEG-OH, acrolyl chloride, and TEA at the respective molar ratio 
of 1:4:6. G3.0-PEG-OH was dissolved in 5 ml of THF. To this solution a mixture 
solution of acrolyl chloride and TEA was added dropwise and stirred for 4 hours. Then 
centrifugation was carried out to remove the salt and the supernatant was collected. The 
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collected supernatant was added dropwise to 40 ml of ethyl ether and kept at -40 ºC for 
further precipitation. The precipitate was extracted and dialyzed to make sure that 
excess of acrolyl chloride was removed. The resulting G3.0-PEG-acrylate was then 
freeze dried 59. G3.5-PEG-OH was converted to G3.5-PEG-acrylate following the same 
procedure as described above. 
Figure 2. Chemistry for introduction of a UV sensitive double bond to PEGylated G3.0 
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3.3.4 Labeling PAMAM dendrimer G3.0 with FITC 
 
To study the distribution of dendrimer within the hydrogel network and observe cell 
internalization PAMAM dendrimer, G3.0 was labeled with florescent dye, i.e. FITC. 
G3.0-PEG-acrylate was dissolved in 2 ml of PBS buffer, and FITC was dissolved in 1 
ml of methanol. The FITC solution was added dropwise to PBS solution of G3.0-PEG 
acrylate in which the molar ratio of amine groups of dendrimer to FITC was 1:1.25. 
This mixture solution was then stirred in dark for 24 hrs. Dialysis was then performed to 
remove the excess amount of FITC. The solution was then freeze dried to obtain FITC 
labeled G3.0-PEG-acrylate. 
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3.3.5  Hydrogel formation 
Three types of photoinitiators (i.e. DMPA, Irgacure, and Eosin Y) were evaluated in 
order to derive the best properties of hydrogels. The one that yielded sol-gel phase 
transition was then applied for hydrogel formation and was subjected to further 
characterization. Three different concentrations of PEG-acrylate (7.5, 20, and 40 wt %) 
were used for hydrogel formation.  The concentration of acrylate was calculated using 
the following equation: 
( ) ( )
( ) / 100 %
m MW of acrylate degreeof PEGylation
x
MW of PEGylated dendrimer
× × = (Equation 1),  
where m= amount of polymer, x = pre determined weight % of polymer used for 
hydrogel formation (i.e. 7.5, 20, 40 wt %)  
For each sample preparation various amount of polymer, with constant acrylate 
concentration was dissolved in 100 µL of DI water. To this 5 µL solution of 
photoinitiator system containing (Eosin Y 0.1%, Triethanolamine [TEOA] 40 % and 1 
vinyl 2 Pyrrolidinone [NVP] 4% by wt) 60 was added. Hydrogel formation was realized 
by subjecting a mixture solution of polymer and photoinitiator to UV radiation [325 nm] 
for 30 min or by curing it under lamp light or a combination of both UV and lamp light. 
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Table 5. Initial screening of photoinitiators and conditions for hydrogel formation 
Polymer*  Photoinitiator  Water 
(µL) 
Duration of 
UV light 
exposure 
(mins) 
G3-[PEG1500-acrylate]29 DMPA 2mg 100 10  
G3-[PEG 6000-acrylate]23  DMPA 2mg 100 10  
G3-[PEG 12000-acrylate]28  DMPA 2mg 100 10  
G3-[PEG 1500-acrylate]29  DMPA 2mg 100 30  
G3-[PEG 6000-acrylate]23 DMPA 2mg 100 30  
G3-[PEG 12000-acrylate]28 DMPA 2mg 100 30 
G3-[PEG 1500-acrylate]29 Irgacure 2mg 100 10  
G3-[PEG 6000-acrylate]23 Irgacure 2mg 100 10
G3-[PEG 12000-acrylate]28 Irgacure 2mg 100 10 
Linear Peg 1500-acrylate DMPA 2 mg , Irgacure, 
EosinY system 
100 10  
G3-[PEG1500-acrylate]29  Eosin Y system 5 µL  100 30  
G3-[PEG 6000-acrylate]23  Eosin Y system 5 µL 100 30  
G3-[PEG 12000-acrylate]28  Eosin Y system 5 µL 100 30  
*= 7.5%wt (Concentration of polymer used for hydrogel formation) 
G3.0-[PEG # -acrylate]* : #, molecular weight of PEG; *, degree of PEGylation; Eosin 
Y system contained Eosin Y 0.1% by wt, Triethanolamine [TEOA] 40 % by wt and 1 
vinyl 2 Pyrrolidinone [NVP] 4% by wt. 
 
 
3.3.6 Formation of hydrogels composed of linear PEG only 
 
For comparative study one of the two hydroxyl end groups of PEG diol [MW 1500] was 
modified to form OH-PEG 1500-acrylate using the same procedure as described for 
modification of PAMAM-PEG-OH in section 3.3.3. The derived product was used to 
form hydrogel utilizing the aforementioned procedure in section 3.3.5. Different 
concentrations such as 2 mg/ 100 µL, 8.2 mg/ 100 µL , 10mg/100 µL of OH-PEG 1500-
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acrylate were utilized for forming hydrogels. In addition the minimum concentration at 
which gelation occurred was determined. 
 
 
3.3.7  Semi-interpenetrating networks 
 
As the formation of hydrogels from low PEGylated dendrimers was not observed, semi 
IPNs were formulated as an alternative strategy. Gelatin, liner OH-PEG 1500-acrylate, 
and linear PEG diol were chosen as a second polymer to form semi IPN with low 
PEGylated dendrimers.  
 
 
3.3.7.1 Semi-IPN composed of low PEGylated dendrimer and gelatin 
 
The molar concentration of acrylate in G3.0-PEG-acrylate with a low degree of 
PEGylation used for forming semi IPNs was kept the same as used in section 3.3.5. 
100mg of gelatin was dissolved in 1 ml of water and heated at 50 °C for 5 minutes to 
dissolve the gelatin completely. This solution was then mixed with a solution containing 
low PEGylated dendrimer in 100 µL of water. To this 5 µL of photo initiator solution 
was added. This solution was subjected to UV radiation for 30 minutes. 
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3.3.7.2 Semi-IPN composed of low PEGylated dendrimer and linear PEG 1500-
acrylate 
The molar concentration of acrylate in PAMAM-PEG-acrylate with a low degree of 
PEGylation was kept the same as used in section 3.3.5. To this solution 2 mg of linear 
PEG-acrylate was added. The concentration of the linear PEG-acrylate used for forming 
semi IPN was much lower than the minimum concentration of linear PEG-acrylate 
alone for forming hydrogels. Both polymers were dissolved in 100 µL of DI water. To 
this solution 5 µL of photoinitiator solution was added. This solution was subjected to 
UV radiation for 30 minutes. 
 
 
3.3.7.3 Semi-IPN composed of low PEGylated dendrimer and linear PEG diol 
Dendrimer-PEG -acrylate with low degree of PEGylation was mixed with linear PEG 
diol (MW 1500) in 100 µL of DI water. To this solution 5 µL of photo initiator solution 
was added. The solution was then subjected to UV radiation for 30 minutes. 
 
 
 
 
 
 
 
 28
3.4 Characterization  
 
3.4.1 Ninhydrin Assay 
 
The remaining amine groups on the surface of dendrimer were quantified by ninhydrin 
assay for indirect determination of the degree of PEGylation of dendrimer. The stock 
solution of ninhydrin was prepared by dissolving 70 mg of ninhydrin in 20 ml of 
ethanol. A sample (1 mg) was dissolved in 1 ml of ethanol or water and then mixed with 
1 ml of ninhydrin stock solution. The mixture was heated at 85 ºC for 5 mins and then 
cooled down to room temperature. The absorbance, at 570 nm was measured with UV-
Vis Spectroscopy. Then the concentration of the amine group was calculated, based on 
standard curve of dendrimer (Figure 3).  
Figure 3. Standard curve of PAMAM dendrimer G3.0 
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The degree of PEGylation was calculated using the following equation: 
( ) ( ) ( )
1 3.0 / 100 32
amine3.0
Volumeof Concentration ofmg PEGylated G n
sample groupsMW of G n MW of PEG
⎡ ⎤ ⎛ ⎞ ⎛ ⎞× × − =⎢ ⎥ ⎜ ⎟ ⎜ ⎟+ ⎝ ⎠ ⎝ ⎠⎣ ⎦
 
(Equation 2) 
where n is degree of PEGylation and G3.0 dendrimer has 32 amine groups.  
 
 
3.4.2 1H-NMR 
 
The 1H-NMR spectra of dendrimer derivatives were recorded on a 400 MHz NMR 
spectrometer (Inova-400). The solvent was deuterium water (D2O), which has a 
chemical shift of 4.8 ppm. The 1H-NMR results were processed using Spinworks 
software. As an alternative method, the degree of PEGylation of dendrimer was 
determined based on the integrals of corresponding proton peaks.  
2
14
A
A
m
Xn =×
       (Equation 3) 
 n= number of protons in PEG’s repeat units ( i.e., 44) 
 m= number of  protons in PAMAM dendrimer G3.0 (i.e., 476) 
 X= degree of PEGylation 
 A1= area under the curve for PEG peak at 3.65ppm 
 A2= relative area under the curve for dendrimer peak between 2.3 ppm and 3 
ppm  
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3.4.3  Water swelling studies 
 
The prepared hydrogel were subjected to swelling test to evaluate the equilibrium water 
content (EWC) within the network. Water swelling experiments were conducted at 
room temperature at different pHs (i.e., 4.4, 2, 7.4, and 10). Prior to evaluation of 
equilibrium water content or calculation of the swelling ratio, the hydrogels were dried. 
Hydrogel samples were accurately weighed prior to immersion into the swelling media. 
The hydrogel samples were taken out periodically from the swelling media, blotted dry 
with an absorbent tissue and weighed. Each water swelling test was carried out over a 
period of 24 hours.  
The second method utilized centrifuge tubes with a membrane having a molecular 
weight cut off of 300 Da. As illustrated in Figure 4, each hydrogel sample was placed in 
the upper chamber of the tube having membrane and incubated in the medium. These 
centrifuge tubes containing hydrogel and the medium were centrifuged at predetermined 
time points. The medium was collected at the bottom tube. The hydrogel was weighed 
and swelling ratio calculated. The hydrogels were put back in the tubes after weighing 
and same procedure was carried out for 24 hours of incubation. The swelling ratio of 
hydrogel was calculated with the following formula; 
100)(% ×−=
Wd
WdWsratioSwelling
 (Equation 4), 
where Ws = weight of swollen hydrogel, Wd = Weight of dry hydrogel.  
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Figure 4. Schematic representation of experimental setup for water swelling studies 
displaying two methods used 
 
 
 
3.4.4 Study of degradation of hydrogels 
 
It was observed that hydrogel degraded to a certain extent during water swelling studies. 
To characterize the degradation of hydrogel, samples were weighed and incubated in 
medium (i.e. neutral, pH of 2, 4.4, 7.4, and 10) in centrifuge tubes. As illustrated in 
Figure 5, centrifugation was carried out after 24 hrs of incubation. The supernatant was 
poured out and subsequently the sample from the bottom portion of centrifuge tube was 
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weighed and utilized to determine swelling ratio. The sample was then freeze dried to 
make sure it was completely free of absorbed medium and weighed again to determine 
the degradation. The degradation extent was calculated using the following equation;  
( )% 100Dw FDwDegradation
Dw
−= ×  (Equation 5), 
Where Dw= Weight of dry hydrogel prior to immersing in medium, FDw = Weight of 
freeze dried hydrogel after 24 hrs of incubation in medium. 
 
Figure 5 Schematic representation of experimental set up for degradation studies 
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3.4.5 Sol-gel phase transition studies 
 
In order to minimize the exposure of UV radiation for hydrogel formation, a 
combination of regular day light and UV radiation was studied. This study was carried 
out to determine the conversion from sol to gel phase over a period of time for 
dendrimer based hydrogel. G3.0-[PEG 12000]28 was used in this study. For this 7.5 
wt % polymer was dissolved in 100 µL of distilled water. To this solution, 5 µL of 
photoinitiator Eosin Y system was added. 12 sample solutions were prepared. Then 
these solutions were allowed to cure under day light for 24 hrs, 48 hrs, 72 hrs and 1 
week; three samples for each time period of curing. After 24 hrs, three samples were 
subjected to UV light for one minute, 5 minutes, and 10 minutes, respectively.  The 
vials were inverted to determine the flow or no flow condition and the time after which 
the flow was seen. Similarly the samples exposed to regular day light for 48, 72 hrs, and 
1 week were subjected to 1, 5, and 10 minutes of UV exposure and tube inversion was 
done to determine the sol-gel transition phase. 
 
 
3.4.6 Scanning electron microscopy (SEM) 
 
To take SEM pictures, sample hydrogel was first mounted on the stub over double sided 
sticky carbon paper, and then the stub with mounted sample was coated with gold for 2 
min and 40 seconds at 30 miliamps. This gold plated stub was then placed inside the 
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SEM chamber under high vacuum. The chamber is equipped with probes for 
visualization of sample placed in the chamber.  
 
 
3.4.7 Analysis of drug release kinetics 
 
To understand the mechanism of release of the active agent from the prepared hydrogels, 
drug Cyclosporine A, which is sparingly soluble in water, was used. Drug loading was 
done in two ways. One way used ethanol as a medium to form hydrogel instead of DI 
water as Cyclosporine A is readily soluble in ethanol. In this method drug was dissolved 
in ethanol with polymer (G3.0-[PEG 12000-acrylate] 3 linear PEG 1500-acrylate) and 
the solution was stirred vigorously. This mixture of polymer and drug was mixed with 
photoinitiator solution and exposed to UV radiation. The second way based on water for 
forming drug incorporated hydrogel is described as follows. First the polymer was 
dissolved in 100 µL DI water. To this solution excess mount of cyclosporine A was 
added. This solution was vortexed vigorously and incubated for 24 hours. After 24 
hours the solution was centrifuged to remove the solids and the supernatant (saturated 
with cyclosporine A) collected and mixed with photoinitiator solution, then exposed to 
UV radiation. It was assumed that the drug would be incorporated within the core of 
dendrimer. Similar procedure was followed for half generation dendrimer (G3.5-[PEG 
1500-acrylate] 43). Linear PEG 1500-acrylate hydrogel was used as control. These 
hydrogel were placed in dialysis bag, and then immersed in 100 ml medium at different 
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pHs (i.e., 2, 7.4, and 10) for 24 hours covered with parafilm and stirring constantly. 
Samples were taken from this solution at predetermined time intervals and analyzed 
using UV–Vis spectrophotometer (Figure 6). The absorbance measured with UV-Vis 
spectrophotometer was compared with the standard curve of cyclosporine A and the 
concentration of the drug was determined (Figure 7 and 8). 
Figure 6 Schematic representation of experimental set up for performing drug release 
kinetics 
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Figure 7. Standard curve of cyclosporine A (water as solvent) 
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Figure 8. Standard curve of cyclosporine A (ethanol as solvent) 
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The total amount of drug released from each hydrogel sample was compared with the 
calculated amount of incorporated drug by measuring the absorbance of the solution of 
polymer and cyclosporine A prior to hydrogel formation. 
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Drug release kinetics was plotted by calculating percentile drug release against a period 
of time. Drug release percentile was calculated as follows: 
 % 100t
i
CDR
C
= ×  (Equation 6) 
Where DR% = drug release %, Ct= Concentration of drug released at time (t), and Ci = 
Concentration of drug at initial time within the hydrogel. 
 
 
3.4.8 Cytotoxicity evaluation 
 
The cytotoxicity of the FITC-conjugated G3.0-PEG was evaluated in vitro using cell 
line RAW264 mouse macrophages. RAW264 mouse macrophages (1×103 cells/well) 
were seeded in a 24-well cell culture plate at 37°C in 1 ml of medium (DMEM medium 
supplemented with 10% fetal calf serum, 100 UI/ml penicillin-streptomycin) in an 
atmosphere of 10% CO2. After 24 h, the culture medium was replaced and different 
amounts of FITC-G3.0-[PEG12000-acrylate] 28 (Mw= 34685) and cross-linked FITC-
G3.0-[PEG12000- acrylate] 28 (Mw= 34685) were added. Their final concentrations 
were 0.2, 2, 20, 50, or 100 µM. The culture plate was then incubated at 37°C in a tissue 
culture incubator for 2 days. After incubation at 37°C for 2 days the medium was 
aspirated and 200 µL of trypsin solution was added to each well to prepare cell 
suspension solution. Then the cell suspension solution together with former medium 
was centrifuged at 3000 rpm for 3min and the supernatant was discarded. The cells 
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were re-suspended in 0.1 ml of PBS or serum-free complete medium and to it 0.1 ml of 
0.4% trypan blue solution added. The mixture was allowed to incubate 3 min at room 
temperature. Then a drop of trypan blue/cell mixture was placed onto a hemacytometer. 
The hemacytometer was then used to count cells. The unstained (viable) cells were then 
counted. 
100% ×=
liquidofmlpercellsofnumberTotal
liquidofmlpercellsviableofnumberTotalViabilityCell (Equation 7) 
 
 
3.4.9  Cell internalization studies 
 
RAW264 mouse macrophages (1×103 cells/well) were seeded in a 24-well cell culture 
plate at 37◦C in 1 ml medium (DMEM medium supplemented with 10% fetal calf serum, 
100 UI/ml penicillin-streptomycin) in an atmosphere of 10% CO2. 
After 24 h, the culture medium was replaced and different concentrations (0.2, 2, 20, 50 
or 100 µM) of FITC-G3.0-[PEG 12000-acrylate]28 (MW= 34685) and cross-linked 
FITC-G3.0-[PEG 12000- acrylate]28 (MW= 34685) were added to the relative medium 
as different groups. After that, in the time point of 15 min, 30 min, 60min, and 24h, 
medium was replaced by new medium for a group of cells. Fluorescence photos were 
taken to determine cell internalization. 
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CHAPTER 4 Results and Discussion 
 
4 Results and Discussion 
4.1 Calculation of degree of PEGylation of dendrimer 
To confirm and calculate the degree of PEGylation of dendrimer (i.e. the average 
number of PEG chains per dendrimer) as well as the molecular weight of PEGylated 
dendrimers ninhydrin assay and 1H-NMR were applied. 
 
 
4.1.1 Ninhydrin assay results 
 The degree of PEGylation was indirectly determined by assessing the number of un-
conjugated amine groups on the dendrimer surface based on ninhydrin. The molecular 
weight was calculated using following equation.  
( ) ( ) ( )[ ]PEGylationofPEGofMWdendrimerofMWdendrimerPEGylatedofMW degree×+=   
(Equation 8) 
A high degree of PEGylation of PAMAM G3.0 dendrimer was achieved regardless of 
PEG length when the feeding molar ratio of PEG to dendrimer was 32:1. The degree of 
  
40
PEGylation was 29 for PEG 1500 (i.e. G3.0-[PEG 1500]29), 23 for PEG 6000 (i.e. G3.0-
[PEG 6000]23), and 28 for PEG 12000 (i.e. G3.0-[PEG 12000]28). The corresponding 
molecular weights of the conjugates were 50460, 144960, and 354960 respectively. 
However, the degree of PEGylation was estimated to be higher than feeding ratio used 
for conjugation when the feeding molar ratio of PEG to dendrimer was low, i.e., 4:1. 
This may be caused by steric hindrance of PEG, which shields the amine groups on the 
surface of dendrimer. Therefore when ninhydrin assay is performed, the number of 
amine groups available for reaction with ninhydrin tends to be lower than what it should 
be, thus leading to estimation of higher loading degree. To overcome this limitation, 1H-
NMR was applied as an alternative method. 
 
 
4.1.2 1H-NMR 
 
The 1H-NMR spectroscopy revealed a very similar degree of PEGylation of dendrimer 
when the feeding molar ratio of PEG to dendrimer was high, i.e., 32:1 (Figure 9, 11, and 
13). As the steric hindrance of PEG affects the ninhydrin assay results, 1H-NMR results 
are more accurate than the ninhydrin assay-based results. When the feeding molar ratio 
of PEG to PAMAM G3.0 was 4:1, the actual degree of PEGylation was 4 for PEG 1500 
(i.e., G3.0-[PEG 1500]4, Figure 10), 3 for PEG 6000 (i.e., G3.0-[PEG 6000]3, Figure 
12), and 3 for PEG 12000 (i.e., G3.0-[PEG 12000]3, Figure 14). The degree of 
PEGylation of half generation PAMAM dendrimers can only be estimated by 1H-NMR 
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as half generation dendrimers do not have amine groups. The degree of PEGylation of 
G3.5 PAMAM dendrimer was 43, (i.e., G3.5-[PEG 1500]43, Figure 15) when the molar 
feeding ratio of PEG to dendrimer was 64:1. 
 
Figure 9. 1H-NMR spectrum of G3.0-[PEG 1500]29  
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Figure 10. 1 H-NMR spectrum of G3.0-[PEG 1500]4  
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Figure 11. 1 H-NMR spectrum of G3.0-[PEG 6000]23 
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Figure 12. 1H-NMR spectrum of G3.0-[PEG 6000]3 
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Figure 13. 1H-NMR spectrum of G3.0-[PEG 12000]28  
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Figure 14. 1H-NMR spectrum of G3.0-[PEG 12000]3  
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Figure 15. 1H-NMR spectrum of G3.5-[PEG 1500]43 
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4.2 Observation on hydrogel formation 
In this study three different photoinitiator, i.e., DMPA, Irgacure, and Eosin Y system, 
were investigated for hydrogel formation. Linear PEG 1500-acrylate was used as 
control. PEGylated dendrimers were dissolved in water to have the same molar 
concentration of acrylate groups as linear PEG-acrylate had. All of the three 
photoinitiators triggered hydrogel formation based on linear PEG 1500-acrylate control 
under the conditions specified in the experiments. We observed that PEGylated 
dendrimers did not form hydrogels with the use of DMPA or Irgacure. In contrast 
PEGylated dendrimers formed hydrogels using the Eosin Y photoinitiator system. 
Hydrogel formation was also affected by PEG length in case of high PEGylated full 
generation dendrimer; higher the PEG length, higher the viscosity of the solution. 
Further the gelation process was shortened when compared to lower PEG lengths under 
the same conditions. As low PEGylated dendrimers alone were unable to form hydrogel, 
a secondary polymer (i.e., gelatin, PEG 1500-acrylate, and PEG 1500 diol) was applied 
to facilitate hydrogel formation of low PEGylated dendrimers. The observation on the 
morphology of hydrogel is enumerated in Table 6. 
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Table 6. Observation on hydrogel formation ( 7.5 % by wt concentration of polymer, 
100 µL of DI water, Eosin Y 0.1% by wt, TEOA 40 % by wt, NVP 4 % by wt, 30 min 
UV radiation) 
 Hydrogel  Polymerization condition after UV radiation for 30 
mins [325 nm] 
A G3-[PEG1500-acrylate]29  Thick viscous liquid, clear, pale yellowish in color 
B G3-[PEG 6000-acrylate]23 Thick viscous liquid, clear, pale yellowish 
C G3-[PEG 12000-acrylate]28  Soft, sticky, clear and pale yellowish hydrogel 
D G3-[PEG 1500-acrylate]4  No gel formation observed, the viscosity did not 
change, clear solution 
E G3-[PEG 6000-acrylate]3  No gel formation observed, the viscosity did not 
change, clear solution 
F G3-[PEG 12000-acrylate]3  No gel formation observed, the viscosity did not 
change, clear solution 
G G3-[PEG 12000-acrylate]3 + 
linear PEG 1500-acrylate  
Soft, sticky, clear and pale yellowish hydrogel 
H Linear PEG 1500-acrylate Soft , clear , pale yellowish hydrogel 
I G3-[PEG 12000-acrylate]3 + 
gelatin 
Soft, sticky, clear and pale yellowish hydrogel 
J G3-[PEG 12000-acrylate]3 + 
linear PEG 1500 
No gel formation observed, the viscosity did not 
change, clear solution 
K G3.5-[PEG 1500-acrylate]43  Soft, flexible, clear hydrogel 
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Figure 16. Appearance of G3-[PEG 12000-acrylate]28 hydrogel after exposure to UV 
radiation 
 
 
Incorporation of linear PEG 1500-acrylate led to formation of semi IPN based on low 
PEGylated dendrimers. It is believed that incorporation of linear PEG 1500-acrylate 
provided more acrylate groups for crosslinking reaction, thus strengthening the network 
formation. To understand the mechanism of hydrogel formation, the concentration of 
linear PEG-acrylate was increased within the semi IPN. It was seen that with higher 
concentrations of linear PEG-acrylate hydrogels improved the structural stability of the 
network. Incorporation of gelatin also helped in IPN formation based on low PEGylated 
dendrimers. Although the mechanism of gelatin facilitating hydrogel formation remains 
to be elucidated, it was believed that addition of gelatin helped to link the dendrimer 
molecules together by reducing the void spaces. However, PEG diol along with low 
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PEGylated dendrimers did not undergo hydrogel formation. Neither gelatin nor PEG 
diol alone is capable of forming hydrogel at the given concentration. 
 
 
4.2.1 Sol-gel phase transition studies 
Hydrogel formation using these three different photoinitiators was evaluated in terms of 
their network structure and sol-gel phase transition. Hydrogel formation was best 
realized using Eosin Y photoinitiator. It was observed that 30 minutes of UV exposure 
was needed for hydrogel formation. The exposure of UV radiation may need to be 
reduced for in situ hydrogel formation. In an attempt to cut down UV exposure, 
solutions of the polymer and photoinitiator were cured under regular day light for 
different time periods first, followed by UV exposure. 
 
Table 7. Sol-gel phase transition of G3.0-[PEG 12000-acrylate]28  
 
Time cured 
in day-light 
24 hours 48 hours 72 hrs 1 week 
Time of 
UV 
exposure 
1 
Min
5 
min 
10 
min 
1 
min
5 
min
10 
min
1 
min
5 
min
10 
min
1 
min  
5 
min 
10 
Min
Flow 
results after 
tube 
inversion 
-- -- - (+) (+) + + + ++ 
 
++ 
 
++ 
 
++ 
 
Instant Flow = -- , Flow after 5 seconds = - , Flow after 10 seconds = (+) , Flow after 20 
second = + , Flow after 30 seconds = ++ 
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Table 7 shows the results of Sol-gel phase transition studies. It was observed that UV 
exposure can be reduced to about 10 minutes with the utilization of combination of two 
sources of curing, regular day light and UV radiation. When the mixture of polymer and 
photoinitiator was allowed to cure in regular day light for a longer time period hydrogel 
formation can be realized with the UV exposure reduced to between 1 and 10 minutes. 
Linear PEG-acrylate was used as control, hydrogel formation was observed after 24 
hours of curing in regular day light without any UV exposure. 
 
 
4.3 Effect of PEG length on hydrogel morphology 
Figure 17. SEM picture of G3.0-[PEG1500-acrylate] 29 hydrogel (magnification 1.97 K) 
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Figure 18. SEM picture of G3-[PEG 6000-acrylate] 23 hydrogel (magnification 1.97 K) 
 
 
Figure 19. SEM picture of G3-[PEG 12000-acrylate] 28 hydrogel (magnification 1.97 K) 
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Figure 20.  SEM picture of linear PEG 1500-acrylate hydrogel (magnification 1.97 K)  
 
 
The SEM pictures of hydrogels were taken to determine the size of particles. The 
images were taken at a magnification of 1.97 K. At this low magnification we were 
unable to reach nanoscale to quantify the size of dendrimer within the hydrogel network. 
Due to the gluey stick characteristic of hydrogel it was not possible to visualize these 
hydrogels at higher magnification. However we still can see the microscopic difference 
in morphology of hydrogels due to PEG lengths variations. 
 
 
4.4  Observation on water swelling studies 
The water swelling results are presented in Figures 21-23. We found that polymer 
composition and pH affected the swelling behavior of the hydrogels. After 24 hours of 
incubation the swelling ratio remained constant for all the samples analyzed. As seen in 
Figure 21 G3.0-[PEG 1500]29 reached the maximum swelling ratio (30 %) within 15 
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minutes of incubation and then its swelling ratio declined to about 3 % after 6 hours and 
remained constant thereafter. The maximum swelling ratio for G3.0-[Peg 6000]23 was 
135.5 % in about 15 minutes and declined to 40 % in around 6 hours and remained 
constant. G3.0-[PEG 12000]28 reached its maximum swelling ratio of 239.64 % in 2 
hours and remained quite constant when observed a period of 24 hours of incubation. 
The control linear PEG 1500-acrylate hydrogel showed a maximum swelling ratio of 
338.33 %. Longer PEG favors a higher swelling ratio and helps the network maintain a 
constant swelling ratio as compared to lower PEG lengths. Hydrogels based on short 
PEG lengths disintegrated upon a short exposure to aqueous swelling medium. Also 
they reached equilibrium faster and most portion of the hydrogel degraded within a 
short period of time (i.e. 2-3 hours). Therefore, the low swelling ratio was probably due 
to mass loss. 
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Figure 21. Swelling ratio of PAMAM dendrimer G3.0 conjugated with different PEG 
lengths  
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A= G3-[PEG 1500-acrylate]29, B= G3-[PEG 6000-acrylate]23, C= G3-[PEG 12000-
acrylate]28 + linear PEG 1500 acrylate, H = Linear PEG 1500-acrylate 
 
It was observed that low PEGylated dendrimers were unable to form hydrogel. 
Therefore forming IPNs was attempted by combining low PEGylated dendrimer with 
linear PEG-acrylate, gelatin, or linear PEG diol. Water swelling studies showed that 
these IPNs displayed pH sensitivity to a certain extent. Full generation dendrimers have 
amine groups on their surface, in case of low PEGylated dendrimer (PEG 12000) these 
surface groups conduce sensitivity to the hydrogel. Figure 22-23 shows that the IPN 
hydrogel reached its swelling equilibrium within 2-3 hours and remained constant 
thereafter as seen from the Figure 22. It was observed that both IPN samples G and I 
had a lower swelling ratio at higher pH (i.e.pH10) than at lower pHs (pH 4.4 and 7.4). 
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The swelling ratio determines the water content held by hydrogel. At a high pH (i.e. pH 
10) due to the presence of cationic surface group the network becomes hydrophobic, 
hence having reduced capability to adsorb water. At neutral pH (i.e. pH 7.4) and even at 
lower pH (i.e. pH 4.4) the network becomes more hydrophilic and is capable of 
absorbing more water. This study demonstrates that linear PEG 1500-acrylate and 
gelatin not only strengthened the network structure of IPNs but make IPNs respond to 
pH change in an appreciable way. 
Figure 22. Result from water swelling study of IPN composed of low PEGylated 
dendrimer G3.0 hydrogel after 24 hours of incubation i.e. at equilibrium swelling 
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G= G3-[PEG 12000-acrylate]3 + linear PEG 1500-acrylate, I= G3-[PEG 12000-
acrylate]3 + Gelatin 
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Figure 23. Comparison of water swelling study of IPN composed of low PEGylated 
dendrimer G3.0 hydrogel and G3.5 dendrimer-PEG (1500) after 24 hours of incubation 
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G= G3-[PEG 12000-acrylate]3 + linear PEG 1500-acrylate, K= G3.5-[PEG 1500-
acrylate]43  
 
Figure 23 gives a comparison of water swelling behavior between full generation (G3.0) 
and half generation dendrimer (G3.5) based hydrogel. The half generation dendrimer 
has carboxyl group on the surface. It was observed that at low pH (i.e. pH 2), half 
generation dendrimer based hydrogel showed a lower swelling ratio (89.9 %) indicating 
less water absorption. It is assumed that the hydrogel network based on G3.5-[PEG 
1500-acrylate]43 becomes hydrophobic at pH 2, and less water is absorbed while, at pH 
10 the network becomes hydrophilic and absorbs more water (i.e., the swelling ratio of 
246% at pH 10). Thus % increase in swelling ratio for G3.5-[PEG 1500-acrylate]43 
from pH 2 to pH 10 is 95.73 %. G3.0-[PEG 12000-acrylate]3 + linear PEG 1500-
acrylate shows high swelling ratio (234.3%) at pH 2 and lower swelling ratio(10%) at 
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basic pH (i.e. pH 10). Thus % decrease in swelling ratio for G3.0-[PEG 12000-
acrylate]3 + linear PEG 1500-acrylate from pH 2 to pH 10 is 173.64 %.  However when 
G3.5-[PEG 1500-acrylate]43 hydrogels were compared with low PEGylated dendrimer 
G3.0-[PEG 12000-acrylate]3, the difference between swelling ratio at high and low pH 
was less pronounced because G3.5-based hydrogels prepared had 43 out of 64 carboxyl 
groups of G3.5 dendrimer that were conjugated with PEG as compared to 3 out of 32 
amine groups conjugated with PEG for low PEGylated G3.0 dendrimer. The higher 
degree of PEGylation reduces the number of exposed surface groups that are 
responsible for pH sensitivity of the network. 
 
 
4.5 Degradation studies 
It was observed that hydrogel degraded during incubation in the medium. Degradation 
degree at different pHs was quantified. The weight of salt entrapped within the matrix 
was neglected in the calculation of degradation ratio as the amount of salt was minimal, 
only accounting for 0.4 wt % of the overall weight of the hydrogel. 
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Figure 24. Degradation of G3-[PEG 12000-acrylate] 28 after 24 hours of incubation  
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Figure 25. Degradation of IPN composed of G3-[PEG 12000-acrylate]3 + linear PEG 
1500-acrylate after 24 hours of incubation  
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Figure 26. Degradation of IPN composed of G3-[PEG 12000-acrylate] 3 + gelatin after 
24 hours of incubation  
0
10
20
30
40
50
60
70
80
90
100
pH 2 pH 4.4 pH 7.4 pH 10
D
eg
ra
da
tio
n 
%
 
As seen in figure 25- 26 the degradation % for G3-[PEG 12000-acrylate]3 + linear PEG 
1500-acrylate at acidic pH was around 80 % while at basic pH was 30 % while G3-
[PEG 12000-acrylate]3 + gelatin showed very low degradation% as compared to G3-
[PEG 12000-acrylate]3 + linear PEG 1500-acrylate. The degradation % was around 
30 % at pH 2, 40 % at pH 4.4 and 50 % at pH 7.4, and 28 % at pH 10. As illustrated 
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form these 2 figures the trend of degradation at different pH varies between G3-[PEG 
12000-acrylate]3 + linear PEG 1500-acrylate.and 3-[PEG 12000-acrylate]3 + gelatin. 
This variation may be attributed by gelatin which might confer some amount of pH 
sensitivity. 
 
Figure 27. Degradation of half generation dendrimer (G3.5-[PEG 1500-acrylate]43 ) 
after 24 hours of incubation 
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Figure 28. Degradation of Linear PEG 1500-acrylate after 24 hours of incubation 
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The degradation results were consistent with water swelling results and further 
confirmed the pH sensitivity of IPNs. From figures 25-27 it can be observed that the 
degradation rate of full generation dendrimer-based IPN was more pronounced at acidic 
pH (i.e. 80% at pH 2) than at basic pH 10 (26.4%). The degradation rate was reduced by 
68.2 %. In contrast, half generation dendrimer-based hydrogel had a higher degradation 
ratio (47%) at pH 10 and a very low degradation ratio 4% at pH 2. The decrease from 
pH 10 to 2 caused decrease in the degradation ratio by 91 %. It was observed that the 
degradation ratio of linear PEG-acrylate hydrogels remained constant at 46 % at 
different pHs. It was also observed that fully PEGylated G3.0 dendrimer have a 
constant degradation ratio of 49% at different pHs. This was due to high degree of 
PEGylation, which significantly reduced the number of available amine groups that are 
responsible for pH sensitivity. 
4.6 Drug release kinetics 
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Typically, researchers predict the release of active drugs as a function of time, using 
simple or sophisticated mathematical models. Diffusion controlled drug release is the 
most widely used model. Cyclosporine A, which is sparingly water soluble, was used as 
a model drug to understand the release kinetics. When the hydrogel is placed in medium, 
the network absorbs water, hence causing swelling of the network and subsequent drug 
release. In our study, hydrogels were placed in dialysis bag and positioned in a beaker 
filled with medium. The amount of drug being released was measured as a function of 
time  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29. Release of cyclosporine A from IPN sample G and H in 100 ml of PBS 
buffer at pH 7.4 (drug encapsulation and IPN preparation was based on ethanol) 
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G= G3-[PEG 12000-acrylate]3 + linear PEG 1500-acrylate, H= Linear PEG 1500-
acrylate 
 
Figure 29 demonstrates release of Cyclosporine A from IPN sample G (G3.0-[PEG 
12000-acrylate]3)+linear PEG 1500-acrylate) hydrogels at pH 7.4 along with control 
linear PEG 1500-acrylate hydrogel which were formed using ethanol. The maximum 
amount of drug released was 2mg. The maximum concentration was quickly reached 
within a short time period (i.e. 40-50 min). 
 
 
 
Figure 30. Release of cyclosporine A from linear PEG 1500-acrylate hydrogel at 
different pHs in 100 ml of medium 
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According to Figure 30, the maximum amount of drug released was 5.77 µg at pH 10, 
1.26 µg at pH 2, and 4.66 µg at pH 7.4. All the hydrogel samples loaded with 
cyclosporine A were prepared under the same condition. Therefore, the actual amount 
of drug loaded into each sample was kept at the same level. However, we see a variation 
in drug release kinetics at different pHs. The drug has amine groups which may play a 
role in exhibiting pH sensitivity even though the network itself, which is made of linear 
PEG, does not. At high pH, the drug becomes more hydrophobic and hence cannot be 
retained by the network and repels the drug and higher release is observed. However at 
low pH the drug can be retained more tightly and released slowly. 
 
 
 
Figure 31. Release of cyclosporine A from full generation dendrimer-based IPN sample 
at different pH in 100 ml of medium 
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It was expected that full generation dendrimer-based hydrogel could release drug more 
slowly at pH 10 than at pH 2, which, however, was not confirmed with our observation. 
The maximum amount of drug released was 5.77 µg at pH 10, 1.31 µg at pH 2, and 4.67 
µg at pH 7.4, which were similar in value to those observed with the control. It was 
believed that the model drug was not appropriate enough as it presents itself with some 
amount of pH sensitivity (Figure 32) which could impact its release. Hence the pH 
sensitivity of the network can not be demonstrated very well as seen with swelling and 
degradation studies. 
 
 
 
 
Figure 32 Structure of 
cyclosporine A 
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Figure 33. Release of cyclosporine A from half generation based dendrimer (G3.5-
[PEG 1500-acrylate] 43) hydrogel at different pHs in 100 ml of medium 
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The release results (Figure 33) were well consistent with what we expected for half 
generation dendrimer-based hydrogel. It was observed that the drug release had a high 
rate at pH 7.4 and pH 10) while a lower rate at pH 2. 
As both pH 7.4 and pH 10 were well above the pKa of carboxylate group on the 
dendrimer surface, the hydrogel had similar hydrophilicity at pH 7.4 and pH 10, 
resulting similar release rates for pH 7.4 and pH 10. Because the hydrogel became 
hydrophobic at pH 2, the release of drug was slowed down due to network shrinking. 
 
 
4.7 Cell cytotoxicity and cell internalization studies 
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We initially evaluated cytotoxicity and internalization of the synthesized nanoparticle 
and nanomatrices by using RAW264 mouse macrophages. Uncrosslinked and 
crosslinked dendrimer-PEG displayed dose-dependent cytotoxicity; however, they had a 
negligible toxic effect on the cells at concentrations of 0.2 µM or below. Trypan Blue 
assay was performed to evaluate the toxic effect of the polymer before and after 
crosslinking. For in vivo application of hydrogel, along with the drug encapsulation and 
release ability, we should ensure that these hydrogels do not cause toxic effects on the 
cell and cause cell death. The cell viability was evaluated in vitro using RAW264 
mouse macrophages cell lines. It was observed that lower the concentration better the 
cell viability for an exposure of 48 hours. It is important that the photoinitiator is 
biocompatible as it may leech out of the hydrogel network and cause adverse reaction. 
There was not much difference in the cell viability at same concentration before and 
after crosslinking with photoinitiator or an exposure period of 48 hours.. Thus it can be 
said that photoinitiator is compatible with the cells for an exposure period of 48 hours. 
A concentration of 0.2 µM showed 100 % cell viability for 48 hours of exposure. It is 
important to evaluate the behavior and interaction of cells when exposed to the polymer 
or when hydrogel is incorporated within the body. Cells were incubated in the polymer 
before forming hydrogel and after hydrogel formation. This would help understand cell 
interaction with the polymer and its distribution with the hydrogel network. Higher 
concentration and longer incubation of uncrosslinked dendrimer-PEG with 
macrophages resulted in stronger particle internalization. Further, the occurrence of the 
internalization of uncrosslinked dendrimer-PEG was observed within 15 minutes. In 
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contrast, internalization of nanomatrices by macrophages was significantly low and 
only observed after 60-min incubation.  
 
Figure 33. Cytotoxicity of FITC-G3.0-[PEG 12000-acrylate] 28 before crosslinking for 
exposure of 48 hours 
0
20
40
60
80
100
120
0 0.2 2 20 50 100
Concentration (µM)
C
el
l v
ia
bi
lit
y 
 %
 
 
 
Figure 35. Cytotoxicity of FITC-G3.0-[PEG 12000-acrylate]28 hydrogel for exposure of 
48 hours 
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4.8   Conclusions 
Our work demonstrated that polyionic hydrogels can be formed using full and half 
generation dendrimers. PEG lengths affect the hydrogel formation in terms of structure 
stability and gelation process. Three different PEGs i.e.1500, 6000, and 12000 were 
covalently conjugated to dendrimer. PEG with MW of 12000 yielded better hydrogel 
formations. The hydrogel formation also varied with the generation of dendrimer used. 
Half generation dendrimer could form better hydrogel with PEG length of 1500 as 
compared to full generation dendrimer conjugated to PEG 1500. The swelling ratio of 
full generation dendrimer G3.0 with a high degree of PEGylation showed no variation 
under different pH conditions as they did not possess enough surface groups, while full 
generation dendrimer with a low degree of PEGylation, demonstrated pH sensitivity in 
terms of swelling and degradation behavior. Also attempts were made to minimize the 
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UV exposure for hydrogel formation so that it can be used for in situ hydrogel 
formation. We demonstrated that hydrogels can be formed by day light exposure over a 
period a time and thereby UV radiation can be avoided, which may be needed in some 
cases. The hydrogels formed from full generation dendrimer can be implemented for 
ocular drug delivery. Since these hydrogels present with cationic charges, they can help 
to have longer retention on the anionic cornea through ionic interactions. This would 
help increase compliance and promote efficient drug delivery. Half generation 
dendrimer-based hydrogels can be used for oral drug delivery as they can react to pH 
gradient. Half generation dendrimer-based hydrogels have maximum swelling ratio at 
basic pH and hence the drug can be diffused out while at acidic pH drug is trapped 
within the hydrogel network. Drug release kinetics demonstrated limited pH sensitivity 
as compared with swelling and degradation studies. A new model drug, pyrene, will be 
used for drug release studies by excluding the pH effect on drug itself.
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CHAPTER 5 Summary and Future Work 
 
5 Summary and Future Work 
5.1 Summary 
With advances in the field of biomaterials, three dimensional crosslinked matrices 
hydrogels have become one of the most widely researched systems for drug delivery. 
These networks can be tailored to deliver drug efficiently and more effectively. 
Dendrimers have been extensively used for drug delivery. However, the research 
developing dendrimer-base hydrogel is limited. Dendrimers present themselves with 
surface charges and this property can be utilized for developing polyionic hydrogels. 
Polyionic hydrogels were formed from full and half generation dendrimer. These 
hydrogels were characterized to quantify their physical morphology, understanding 
swelling behavior, and drug release kinetics for a range of pH. The study was 
accompanied with PEG hydrogels as control.  
It was seen that realization of hydrogel formation and swelling behavior varied with 
different molecular weight of PEG conjugated to dendrimer. Higher PEG length 
resulted in more stable hydrogel formation and higher swelling ratio.  The hydrogel 
network developed in this project is highly adaptable. It can be engineered for various 
applications. As the dendrimer network has inner hydrophobic cores included, both 
hydrophobic and hydrophilic drugs can be loaded. This network can be either 
  
71
polyanionic or polycationic. Till date research on dendrimer based hydrogels43, 53, 60 
have been limited in terms of exhibiting pH sensitivity. Hence, the new dendrimer-
based polyionic hydrogel network developed in this study will find a wide range of 
applications. 
 
5.2 Future work 
This study attempted to characterize physical properties, swelling kinetics and drug 
release kinetics of dendrimer based hydrogels for biomedical applications. Presently 
only swelling, degradation studies, and drug kinetics were done at room temperature 
and different pH conditions. Future work should involve expansion of this study at 
different temperature as well. One of the potential applications of hydrogel would be 
ocular drug delivery. Ocular drug delivery can be targeted as these hydrogels have 
positive charges, hence help adhere to cornea possessing negative charges. This 
mechanism can help to increase the residence time of hydrogel in the eye, thereby 
delivering right amount of drug without repeated dosing. We have studied the release 
kinetics of drug Cyclosporine A. The drug presented with some difficulties. The drug 
itself can present with some pH sensitivity. Hence a better model drug such as pyrene 
could be used for drug release kinetics. This procedure had limitations as the hydrogel 
structure was not stable. Hence when the network breaks down, though the disintegrated 
network can be held within the dialysis bag, the drug diffuses out thus interfering with 
the results of release mechanism. Hence the method to be used for experimenting 
release mechanism shall be optimized for obtaining accurate results. Future work should 
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involve more appropriate ways of estimating release of drug from hydrogel such as 
using mathematical models. It was observed that these hydrogel demonstrated some 
degree of adhesiveness, thus testing the tissue adhesive and mechanical properties will 
help to determine its use as a sealant for wound closure of tissue and also as 
mucoadhesive drug delivery application. Future work should involve mechanical testing 
either by using texture analyzer or other similar instruments which would help measure 
the viscosity of these hydrogel. 
As emphasized previously, the hydrogel should be biocompatible in order to be used in 
biomedical applications. Hydrogels synthesized in the present work were tested in vitro, 
which provides sufficient preliminary evidence on the biocompatibility of the hydrogels. 
The cell line used was RAW264 mouse macrophages which is not universally used for 
testing cytotoxicity. The cytoxicity will be evaluated in a more rigorous way using L929 
mouse fibroblasts, a standard cell line for cytotoxicity evaluation. However, in vivo 
tests are more important as they provide a better image of the biocompatibility nature of 
a biomaterial. Thus as a suggestion for future work, in vivo studies involving clinical 
trials on the hydrogels prepared in the present work would provide a better 
understanding of their biocompatibility. Furthermore, in vivo studies will confirm the 
findings from this work on the suitability of these materials for biomedical use. 
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